Research
-
KLUYVEROMYCES MARXIANUS FRAGILIS B0399 - CHARACTERIZATION & IDENTIFICATION
- Key features and benefits
°natural resistance to gastric conditions
°natural antibiotic resistance and compatibility with a-biotic therapy
°effective dosage and concentration
- Distinguishing genotypic and phenotypic characteristics -
HUMAN HEALTH
A great network with universities and research institutes world-wide enabled Turval to focus our scientific efforts and build solid scientific research on the use of Probiotic Lactic Yeast, Kluyveromyces marxianus fragilis B0399 (TURVAL B0399) in four key health areas: gut, oral, women's and immune health.
-
FOOD SCIENCE & TECHNOLOGY INNOVATION
Nowadays probiotic delivery has been widely associated with different foods (especially dairy). However, most of the commonly used probiotic bacteria do not survive stomach acid environment unless incorporated into specific encapsulating materials that can protect them during food storage and gastrointestinal transit - the process which negatively effects a probiotic cost-effectiveness.
Selection of the adequate gastro-resistant and shelf stable probiotic strain, such as Turval B0399, and selection of the adequate food system to deliver the probiotics, are two vital factors to be considered when developing functional, probiotic food products. - ANIMAL HEALTH